Reprieve Cardiovascular Partners with Leading Heart Failure Researchers and Truveta to Analyze Real-World Heart Failure Patient Data

Reprieve Cardiovascular, Inc. (‘Reprieve’), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart Failure.